Vpu: A multifunctional protein that enhances the pathogenesis of human immunodeficiency virus type 1

被引:29
作者
Hout, DR [1 ]
Mulcahy, ER [1 ]
Pacyniak, E [1 ]
Gomez, LM [1 ]
Gomez, ML [1 ]
Stephens, EB [1 ]
机构
[1] Univ Kansas, Med Ctr, Dept Anat & Cell Biol, Kansas City, KS 66160 USA
关键词
Vpu; HIV-1; pathogenesis; SHIV; CD4; virion release;
D O I
10.2174/1570162043351246
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The Vpu protein is the smallest of the proteins encoded by human immunodeficiency virus type I (HIV-1). This transmembrane protein interacts with the CD4 molecule in the rough endoplasmic reticulum (RER), resulting in its degradation via the proteasome pathway. Vpu also has been shown to enhance virion release from infected cells. While much has been learned about the function of Vpu in cell culture systems, its exact role in HIV-1 pathogenesis is still unknown. This has been primarily due to the lack of a Suitable primate model system since vpu is found only in HIV-1 and simian immunodeficiency viruses isolated from chimpanzees (SIVcpz), and three species of old world monkeys within the genus Cercopithecus. Several laboratories have developed pathogenic molecular clones of simian-human immunodeficiency virus (SHIV) in which the tat, rev, vpu and env genes of HIV-1 are expressed in the genetic background of SIV. The availability of such clones has allowed investigators to assess the role of Vpu in pathogenesis using a relevant animal model. This review will focus on the current understanding of the structure-function relationships of Vpu protein and recent advances using the SHIV model to assess the role of Vpu in HIV-1 pathogenesis.
引用
收藏
页码:255 / 270
页数:16
相关论文
共 127 条
[1]   The human immunodeficiency virus type 1 accessory protein Vpu induces apoptosis by suppressing the nuclear factor κB-dependent expression of antiapoptotic factors [J].
Akari, H ;
Bour, S ;
Kao, S ;
Adachi, A ;
Strebel, K .
JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 194 (09) :1299-1311
[2]   Pathogenesis of human immunodeficiency virus-induced neurological disease [J].
Albright, AV ;
Soldan, SS ;
González-Scarano, F .
JOURNAL OF NEUROVIROLOGY, 2003, 9 (02) :222-227
[3]   Nef: agent of cell subversion [J].
Arora, VK ;
Fredericksen, BL ;
Garcia, JV .
MICROBES AND INFECTION, 2002, 4 (02) :189-199
[4]   SKP1 connects cell cycle regulators to the ubiquitin proteolysis machinery through a novel motif, the F-box [J].
Bai, C ;
Sen, P ;
Hofmann, K ;
Ma, L ;
Goebl, M ;
Harper, JW ;
Elledge, SJ .
CELL, 1996, 86 (02) :263-274
[5]   Hybrid origin of SIV in chimpanzees [J].
Bailes, E ;
Gao, F ;
Bibollet-Ruche, F ;
Courgnaud, V ;
Peeters, M ;
Marx, PA ;
Hahn, BH ;
Sharp, PM .
SCIENCE, 2003, 300 (5626) :1713-1713
[6]   Characterization of a novel simian immunodeficiency virus (SIVmonNG1) genome sequence from a mona monkey (Cercopithecus mona) [J].
Barlow, KL ;
Ajao, AO ;
Clewley, JP .
JOURNAL OF VIROLOGY, 2003, 77 (12) :6879-6888
[7]   The di-leucine motif in the cytoplasmic tail of CD4 is not required for binding to human immunodeficiency virus type 1 Nef, but is critical for CD4 down-modulation [J].
Bentham, M ;
Mazaleyrat, S ;
Harris, M .
JOURNAL OF GENERAL VIROLOGY, 2003, 84 :2705-2713
[8]   HIV-1 Vpu sequesters β-transducin repeat-containing protein (βTrCP) in the cytoplasm and provokes the accumulation of β-catenin and other SCFβTrCP substrates [J].
Besnard-Guerin, C ;
Belaïdouni, N ;
Lassot, I ;
Segeral, E ;
Jobart, A ;
Marchal, C ;
Benarous, R .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (01) :788-795
[9]   THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 VPU PROTEIN SPECIFICALLY BINDS TO THE CYTOPLASMIC DOMAIN OF CD4 - IMPLICATIONS FOR THE MECHANISM OF DEGRADATION [J].
BOUR, S ;
SCHUBERT, U ;
STREBEL, K .
JOURNAL OF VIROLOGY, 1995, 69 (03) :1510-1520
[10]   Cell surface CD4 inhibits HTV-1 particle release by interfering with Vpu activity [J].
Bour, S ;
Perrin, C ;
Strebel, K .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (47) :33800-33806